Revelation Biosciences, Inc. (REVB)
$0.77+1.32%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3M
- Beta
- -0.17
- P/E (TTM)
- -0.11
- Short % float
- 0.05%
- Days to cover
- 1.0
- SI change
- +517.6%
- 1W
- -1.28%
- 1M
- -22.22%
- vs SPY 1W
- -1.70%
- vs SPY 1M
- -24.28%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on REVB?
- LOPJLB’s latest quantitative signal on Revelation Biosciences, Inc. (REVB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is REVB in?
- Revelation Biosciences, Inc. (REVB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Revelation Biosciences, Inc. (REVB) do?
- Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting the immune system. The company's therapeutic pipeline includes promising candidates such as GEM-AKI, which is being developed as a potential therapy for both the prevention and management of acute ki…